Australian Clinical Labs
ACL.AX
#6842
Rank
NZ$0.76 B
Marketcap
$3.78
Share price
-0.58%
Change (1 day)
35.78%
Change (1 year)

Operating Margin for Australian Clinical Labs (ACL.AX)

Operating Margin at the end of 2023: 6.98%

According to Australian Clinical Labs's latest financial reports and stock price the company's current Operating Margin is 6.98%. At the end of 2023 the company had an Operating Margin of 6.98%.

Operating Margin history for Australian Clinical Labs from 2021 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
20236.98%-72.91%
202225.77%90.69%
202113.51%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.